Reaction
Truncus Arteriosus Persistent reporting signals
As of the last recalculation, Truncus Arteriosus Persistent appears in 199 FAERS reports alongside 13 co-occurring drug terms. The strongest observed disproportionality signal is NICOTINE POLACRILEX MINI (PRR 820.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Nicotine Polacrilex Mini | 74 | 820.6 | 824.7 |
| Nicotine Polarilex | 74 | 820.6 | 824.7 |
| Misoprostol | 41 | 554.4 | 556.7 |
| Dalteparin Sodium | 43 | 542.1 | 544.3 |
| Nicotine | 77 | 324.2 | 324.8 |
| Nicotine Polacrilex | 74 | 321.4 | 322.0 |
| Torsemide | 40 | 157.8 | 158.0 |
| Ezetimibe | 71 | 153.4 | 153.6 |
| Hydroxychloroquine | 65 | 134.8 | 134.9 |
| Tacrolimus Ointment 0.1% | 77 | 104.9 | 104.9 |
| Tacrolimus Extended-Release Capsules | 77 | 104.6 | 104.6 |
| Enoxaparin Sodium | 41 | 93.6 | 93.7 |
| Rivaroxaban | 82 | 69.4 | 69.4 |